Saturday, December 3, 2022

AIIMS Delhi begins clinical Covaxin trials on children in 12-18 age group

AIIMS Delhi has begun screening for clinical trials of Covaxin, Covid-19 vaccine, on children from today, as per ANI. 

The trial is planned on 525 subjects at various sites, including AIIMS of Delhi and Patna, as well as of Meditrina Institute of Medical Sciences, Nagpur. 

The two doses would be administered at an interval fo 28 days. 

Covaxin will be the first such vaccine in India that would cater to inoculating children. 

AIIMS Patna has already begun trials in the 12-18 age group. After them, it would be trials on 6-12 years and then 2-6 years. 

On May 13, the Drugs Controller General of India (DCGI) had given nod to phase-2/3 trials on children ageing 2-18-year-olds. 


Read More

Marriage rates are falling alarmingly in China

China’s annual rate of new marriages has fallen to the lowest point in more than three decades, contributing to the country’s already declining birth...
Support Us
Contribute to see NewsBred grow. And rejoice that your input has made it possible.